Long-term therapy for heart failure with continuous ambulatory peritoneal dialysis

Area of Science:

• Nephrology
• Cardiology
• Internal Medicine

Background:

• Intractable congestive heart failure (CHF) poses significant management challenges, particularly when secondary to ischemic cardiomyopathy.
• Traditional treatments for refractory heart failure are often limited in efficacy.
• Peritoneal dialysis (PD) has emerged as a potential therapeutic option for fluid management in advanced heart failure.

Observation:

• A patient with severe, intractable congestive heart failure due to ischemic cardiomyopathy was treated with continuous ambulatory peritoneal dialysis (CAPD).
• The CAPD system allowed for effective fluid removal and management over an extended period.
• This treatment approach aimed to alleviate symptoms and improve quality of life in a patient refractory to conventional therapies.

Findings:

• The two-year treatment interval with CAPD represents the longest reported duration for managing intractable congestive heart failure secondary to ischemic cardiomyopathy.
• Continuous ambulatory peritoneal dialysis demonstrated sustained efficacy in managing fluid overload in this challenging patient population.
• The study highlights the feasibility and potential long-term benefits of CAPD in selected cases of refractory heart failure.

Implications:

• Continuous ambulatory peritoneal dialysis may offer a viable, long-term therapeutic strategy for patients with severe heart failure unresponsive to standard treatments.
• This extended application of CAPD suggests its potential role in improving outcomes for patients with complex cardiovascular and renal comorbidities.
• Further research into the long-term effects and patient selection criteria for CAPD in heart failure management is warranted.